NASDAQ:PHAT

Phathom Pharmaceuticals Stock Predictions

etoro logo Buy PHAT
*Your capital is at risk
$10.09
+0.440 (+4.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PHAT Prediction Chart

PHAT Predictions History

Latest community submissions for PHAT.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 17, 2024 $11.17 -1.61% $11.70 X 95.45% 0
Jun 17, 2024 Bullish $11.70 V 1
JS JS Pro
Oct 3, 2022 $11.21 +1.17% $9.86 X 86.31% 0
Oct 3, 2022 $10.61 -4.23% $9.86 V 92.38% 1
Oct 3, 2022 $10.15 -8.37% $9.86 V 97.04% 1
Oct 3, 2022 Bullish $9.86 X 0
JS JS Pro
Sep 19, 2022 $10.52 +1.35% $10.05 X 95.32% 0
Sep 19, 2022 $9.91 -4.50% $10.05 V 98.63% 2
Sep 19, 2022 $8.94 -13.84% $10.05 V 88.99% 1
Sep 19, 2022 Bullish $10.05 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PHAT with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PHATHOM PHARMACEUTICALS, INC.
Phathom Pharmaceuticals
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE